- Home
- FLYX vs SER Comparison
FLYX vs SER Comparison
Compare FLYX & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- SER
- Stock Information
- Founded
- FLYX 2015
- SER 2017
- Country
- FLYX United States
- SER United States
- Employees
- FLYX N/A
- SER N/A
- Industry
- FLYX Blank Checks
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- FLYX Finance
- SER Health Care
- Exchange
- FLYX Nasdaq
- SER Nasdaq
- Market Cap
- FLYX 54.1M
- SER 56.5M
- IPO Year
- FLYX N/A
- SER 2018
- Fundamental
- Price
- FLYX $2.06
- SER $6.14
- Analyst Decision
- FLYX
- SER Strong Buy
- Analyst Count
- FLYX 0
- SER 1
- Target Price
- FLYX N/A
- SER $11.00
- AVG Volume (30 Days)
- FLYX 19.7K
- SER 16.6K
- Earning Date
- FLYX 08-13-2025
- SER 08-08-2025
- Dividend Yield
- FLYX N/A
- SER N/A
- EPS Growth
- FLYX N/A
- SER N/A
- EPS
- FLYX N/A
- SER N/A
- Revenue
- FLYX $335,427,000.00
- SER $51,000.00
- Revenue This Year
- FLYX $28.47
- SER N/A
- Revenue Next Year
- FLYX $22.44
- SER N/A
- P/E Ratio
- FLYX N/A
- SER N/A
- Revenue Growth
- FLYX 5.38
- SER N/A
- 52 Week Low
- FLYX $1.79
- SER $3.81
- 52 Week High
- FLYX $5.19
- SER $11.57
- Technical
- Relative Strength Index (RSI)
- FLYX 34.41
- SER 56.40
- Support Level
- FLYX $1.90
- SER $5.50
- Resistance Level
- FLYX $2.89
- SER $6.29
- Average True Range (ATR)
- FLYX 0.30
- SER 0.47
- MACD
- FLYX -0.06
- SER 0.02
- Stochastic Oscillator
- FLYX 15.33
- SER 80.36
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.